Cappoli, Natalia
 Distribuzione geografica
Continente #
NA - Nord America 283
EU - Europa 264
AS - Asia 66
SA - Sud America 13
OC - Oceania 6
AF - Africa 1
Totale 633
Nazione #
US - Stati Uniti d'America 278
IT - Italia 127
SE - Svezia 57
CN - Cina 28
DE - Germania 22
FR - Francia 18
IE - Irlanda 13
SG - Singapore 12
BR - Brasile 9
GB - Regno Unito 8
AU - Australia 6
IN - India 5
IR - Iran 5
BE - Belgio 4
CL - Cile 4
CZ - Repubblica Ceca 4
CA - Canada 3
FI - Finlandia 3
JP - Giappone 3
RU - Federazione Russa 3
HK - Hong Kong 2
IL - Israele 2
LT - Lituania 2
MN - Mongolia 2
MX - Messico 2
MY - Malesia 2
TR - Turchia 2
UA - Ucraina 2
AE - Emirati Arabi Uniti 1
CH - Svizzera 1
CI - Costa d'Avorio 1
KR - Corea 1
TW - Taiwan 1
Totale 633
Città #
Chandler 72
Ashburn 31
New York 25
Verona 25
Rome 23
Milan 17
Dublin 13
Marseille 13
Beijing 11
Scottsdale 10
Philadelphia 8
San Mateo 8
Seattle 8
Bremen 7
Princeton 7
Ann Arbor 6
Cagliari 6
Singapore 6
Sydney 6
Wilmington 6
Boston 5
Ferrara 5
Athens 4
Brasília 4
Brussels 4
Cattolica 4
Los Angeles 4
Nanjing 4
Naples 4
Redmond 4
Salvador 4
San Giovanni la Punta 4
Santiago 4
Tampa 4
Lake Forest 3
Moscow 3
Mumbai 3
Nuremberg 3
Otemae 3
Washington 3
Busto Arsizio 2
Cambridge 2
Catania 2
Dearborn 2
Fairfield 2
Foggia 2
Gustavo Adolfo Madero 2
Helsinki 2
Hong Kong 2
Munich 2
Pavia 2
Pisa 2
Redwood City 2
Vancouver 2
Šiauliai 2
Abidjan 1
Atlanta 1
Augusta 1
Bern 1
Bologna 1
Brno 1
Böblingen 1
Castenaso 1
Chicago 1
Freiburg im Breisgau 1
George Town 1
Hoschton 1
Istanbul 1
Izmir 1
Jerusalem 1
Jiaxing 1
Kish 1
Kunming 1
Lappeenranta 1
Leawood 1
London 1
Madison 1
Monmouth Junction 1
Napoli 1
New Bedfont 1
Padova 1
Petaling Jaya 1
Provo 1
Ramacca 1
Roncoferraro 1
Salò 1
Sari 1
Secaucus 1
Shanghai 1
Taipei 1
Tehran 1
Tianjin 1
Tucson 1
Winnipeg 1
Woodbridge 1
Totale 454
Nome #
The human microglial HMC3 cell line: where do we stand? A systematic literature review 163
Effects of remifentanil on human C20 microglial pro-inflammatory activation 141
The mTOR kinase inhibitor rapamycin enhances the expression and release of pro-inflammatory cytokine interleukin 6 modulating the activation of human microglial cells 78
A comparison between the assessments of progression-free survival by local investigators versus blinded independent central reviews in phase III oncology trials 64
The emerging role of the BDNF-TrkB signaling pathway in the modulation of pain perception 64
Local Investigators Significantly Overestimate Overall Response Rates Compared to Blinded Independent Central Reviews in Phase 2 Oncology Trials 57
LAT1, a novel pharmacological target for the treatment of glioblastoma 36
REMIFENTANIL DOES NOT AFFECT HUMAN MICROGLIAL IMMUNE ACTIVATION IN RESPONSE TO PRO-INFLAMMATORY CYTOKINES 34
Remifentanil-induced hyperalgesia in healthy volunteers: a systematic review and meta-analysis of randomized controlled trials 19
Exploring the Control of PARP1 Levels in High-Grade Serous Ovarian Cancer 3
Totale 659
Categoria #
all - tutte 2.770
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 2.770


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202027 0 0 2 6 2 3 3 2 3 3 2 1
2020/202129 1 0 0 6 1 3 0 2 6 1 9 0
2021/2022116 10 1 1 12 6 2 11 10 3 4 41 15
2022/2023218 34 22 10 31 25 17 23 15 18 6 13 4
2023/2024235 9 24 14 22 12 37 19 6 4 23 35 30
2024/202516 13 3 0 0 0 0 0 0 0 0 0 0
Totale 659